The Food and Drug Administration today ordered Custom Ultrasonics to recall all of its automated endoscope reprocessors from health care facilities, citing violations that could result in an increased risk of infection. Hospitals and other facilities using the AERs should transition as soon as possible to alternative reprocessing methods that are compatible with their flexible endoscopes, and report any infections that may be related to the recalled reprocessors to the company and the FDA MedWatch program, the agency said